Efficacy observation of cetrorelix combined with aspirin in preventing early-onset ovarian hyperstimulation syndrome

ZHANG Yingying; ZHANG Yile; SHI Hao; BU Zhiqin; YANG Li; MENG Yanlei; GUO Yihong

doi:10.6039/j.issn.1001-0408.2024.16.12

您当前的位置：

首页 >

文章列表页 >

Efficacy observation of cetrorelix combined with aspirin in preventing early-onset ovarian hyperstimulation syndrome

更新时间：2024-08-23

- Efficacy observation of cetrorelix combined with aspirin in preventing early-onset ovarian hyperstimulation syndrome
- ZHONGGUO YAOFANG Vol. 35, Issue 16, Pages: 2009-2012(2024)
- 作者机构：
  
  郑州大学第一附属医院生殖与遗传专科医院生殖医学中心，郑州　450052
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2024.16.12
  CLC： R711;R984
- Published：30 August 2024，
  
  Received：12 January 2024，
  
  Revised：09 July 2024，
- 稿件说明：
扫描看全文
张莹莹,张轶乐,史昊等.西曲瑞克联合阿司匹林预防早发型卵巢过度刺激综合征的疗效观察 ^Δ[J].中国药房,2024,35(16):2009-2012.

ZHANG Yingying,ZHANG Yile,SHI Hao,et al.Efficacy observation of cetrorelix combined with aspirin in preventing early-onset ovarian hyperstimulation syndrome[J].ZHONGGUO YAOFANG,2024,35(16):2009-2012.
张莹莹,张轶乐,史昊等.西曲瑞克联合阿司匹林预防早发型卵巢过度刺激综合征的疗效观察 ^Δ[J].中国药房,2024,35(16):2009-2012. DOI： 10.6039/j.issn.1001-0408.2024.16.12.

ZHANG Yingying,ZHANG Yile,SHI Hao,et al.Efficacy observation of cetrorelix combined with aspirin in preventing early-onset ovarian hyperstimulation syndrome[J].ZHONGGUO YAOFANG,2024,35(16):2009-2012. DOI： 10.6039/j.issn.1001-0408.2024.16.12.

摘要

目的

观察西曲瑞克联合阿司匹林预防早发型卵巢过度刺激综合征（OHSS）的疗效。

方法

回顾性收集2022年1月1日至7月1日于我院治疗的38例早发型OHSS患者资料，根据用药方案的不同分为对照组（19例）和干预组（19例）。取卵术后第1天，对照组患者给予阿司匹林肠溶片100 mg，口服至月经来潮；干预组患者给予注射用西曲瑞克0.25 mg，连续3 d皮下注射+阿司匹林肠溶片（用法用量同对照组）。观察并检测两组患者的首个黄体期、OHSS严重程度分级及取卵术后卵巢体积、腹水体积、血清雌二醇（E

）、白细胞计数（WBC）、红细胞比容（HCT）、中性粒细胞百分比（NEUT%）、D-二聚体（DD）、凝血酶原时间（PT）、纤维蛋白原（Fib）。

结果

干预组患者的首个黄体期显著短于

对照组，中、重度患者比例显著低于对照组（

＜0.05或

＜0.01）。取卵术后，干预组患者的卵巢体积、腹水体积、血清E

、WBC、NEUT%、HCT、DD、Fib总体低于对照组，PT显著高于对照组（

＜0.05）

。

结论

西曲瑞克联合阿司匹林预防早发型OHSS的疗效较单用阿司匹林更好。

Abstract

OBJECTIVE

To observe the efficacy of cetrorelix combined with aspirin in preventing early-onset ovarian hyperstimulation syndrome （OHSS）.

METHODS

A retrospective analysis was conducted on clinical data from 38 early-onset OHSS patients， who received treatment in our hospital from January 1st to July 1st， 2022. These patients were divided into intervention group （19 cases） and control group （19 cases） according to the therapy regimen. On the first day after oocyte retrieval surgery， the control group was given aspirin enteric-coated tablets 100 mg orally until menstruation began. The intervention group was given cetrorelix for injection 0.25 mg subcutaneously， for consecutive 3 days+aspirin enteric-coated tablets （same usage and dosage as the control group）. The first luteal phase， the degree of OHSS， and the ovarian volume， ascites volume， serum estradiol （E

）， white blood cell count （WBC）， hematocrit （HCT）， neutrophil ratio （NEUT%）， D-dimer （DD）， prothrombin time （PT）， fibrinogen （Fib） after oocyte retrieval surgery were observed and measured in 2 groups.

RESULTS

The first luteal phase was significantly shorter， and the proportions of median and severe OHSS cases were significantly lower in the intervention group compared to the control group （

＜0.05 or

＜0.01）. After oocyte retrieval surgery， the intervention group showed significantly lower ovarian volume， ascites volume， serum E

， WBC， NEUT%， HCT， DD and Fib compared to the control group， but PT of intervention group was signiticantly higher than that of control group （

＜0.05）.

CONCLUSIONS

Cetrorelix combined with aspirin is more effective in preventing early-onset OHSS than aspirin alone.

关键词

卵巢过度刺激综合征西曲瑞克阿司匹林卵泡期长效长方案促排卵

Keywords

cetrorelixaspirinlong-lasting follicular phase protocolovulation induction

references

BLUMENFELD Z. The ovarian hyperstimulation syndrome[J]. Vitam Horm，2018，107：423-451.

TIMMONS D，MONTRIEF T，KOYFMAN A，et al. Ova-rian hyperstimulation syndrome：a review for emergency clinicians[J]. Am J Emerg Med，2019，37（8）：1577-1584.

赵晓鹏，李楠，白俊，等. 辅助生殖技术助孕后OHSS并发血栓的文献回顾性分析[J]. 中国优生与遗传杂志，2022，30（8）：1419-1423.

ZHAO X P，LI N，BAI J，et al. Retrospective analysis of OHSS complicated with thrombosis following assisted reproduction technology[J]. Chin J Birth Health Hered，2022，30（8）：1419-1423.

宋荣，李寿梅，石金月，等. 促性腺激素释放激素拮抗剂在防治早发型中重度卵巢过度刺激综合征的应用[J]. 中华生殖与避孕杂志，2018，38（3）：175-180.

SONG R，LI S M，SHI J Y，et al. Application of gonadotropin-releasing hormone antagonist in the prevention and treatment of early ovarian hyperstimulation syndrome[J]. Chin J Reprod Contracept，2018，38（3）：175-180.

梁晓燕. 辅助生殖临床技术：实践与提高[M]. 北京：人民卫生出版社，2018：539-545.

LIANG X Y. Clinical techniques for assisted reproduction：practice and improvement[M]. Beijing：People’s Medical Publishing House，2018：539-545.

ELMAHDY M，ABDELSALAM E A，MAGHRABY H A. Combining several interventions to reduce the incidence of OHSS：a prospective cohort study[J]. Eur J Obstet Gynecol Reprod Biol，2017，212：110-114.

哈灵侠，黎维霞，吴阳阳，等. 思则凯在预防早期中重度卵巢过度刺激综合征的应用[J]. 山东大学学报（医学版），2020，58（6）：60-64.

HA L X，LI W X，WU Y Y，et al. Effect of cetrorelix on early moderate and severe ovarian hyperstimulation syndrome[J]. J Shandong Univ（Health Sci），2020，58（6）：60-64.

Royal College of Obstetricians & Gynaecologists. The management of ovarian hyperstimulation syndrome（green-top guideline No.5）[EB/OL]. [2023-12-12]. https：//www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/ the-management-of-ovarian-hypersti-mulation-syndrome-green-top-guideline-no-5/https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/the-management-of-ovarian-hypersti-mulation-syndrome-green-top-guideline-no-5/.

HUMAIDAN P，NELSON S M，DEVROEY P，et al. Ovarian hyperstimulation syndrome：review and new classification criteria for reporting in clinical trials[J]. Hum Reprod，2016，31（9）：1997-2004.

NASTRI C O，TEIXEIRA D M，MORONI R M，et al. Ovarian hyperstimulation syndrome：pathophysiology，staging，prediction and prevention[J]. Ultrasound Obstet Gynecol，2015，45（4）：377-393.

KOH H，KIM S D，YANG H. Ischemic stroke associated with ovarian hyperstimulation syndrome[J]. J Emerg Med，2021，61（3）：320-324.

赵晓鹏，陈桂芝，常飞，等. 卵巢过度刺激综合征并发血栓栓塞[J]. 生殖与避孕，2015，35（9）：644-649.

ZHAO X P，CHEN G Z，CHANG F，et al. Ovarian hyperstimulation syndrome complicating with thrombosis[J]. Chin J Reprod Contracept，2015，35（9）：644-649.

SUN B，MA Y J，LI L，et al. Factors associated with ova-rian hyperstimulation syndrome（OHSS）severity in women with polycystic ovary syndrome undergoing IVF/ICSI[J]. Front Endocrinol，2020，11：615957.

CRESCENTE M，ARMSTRONG P C，KIRKBY N S，et al. Profiling the eicosanoid networks that underlie the anti- and pro-thrombotic effects of aspirin[J]. FASEB J，2020，34（8）：10027-10040.

王璐，穆莎，左世栋，等. 重度卵巢过度刺激综合征患者高凝趋势及预后分析[J]. 解放军医学院学报，2022，43（4）：390-394.

WANG L，MU S，ZUO S D，et al. Hypercoagulability and prognosis in patients with severe ovarian hyperstimulation syndrome[J]. Acad J Chin PLA Med Sch，2022，43（4）：390-394.

ZENG C，SHANG J，JIN A M，et al. The effect of luteal GnRH antagonist on moderate and severe early ovarian hyperstimulation syndrome during in vitro fertilization treatment：a prospective cohort study[J]. Arch Gynecol Obstet，2019，300（1）：223-233.

MILLS G，DAHAN M H. Gonadotropin releasing hormone（GnRH）antagonist administration to decrease the risk of ovarian hyperstimulation syndrome in GNRH agonist cycles triggered with human chorionic gonadotropin[J]. Arch Gynecol Obstet，2022，306（5）：1731-1737.

夏旖，谢青贞，张祎明. 取卵后使用GnRH-拮抗剂联合米非司酮和来曲唑预防早发型中重度OHSS：一项随机对照研究[J]. 生殖医学杂志，2019，28（7）：730-735.

XIA Y，XIE Q Z，ZHANG Y M. Clinical effect of GnRH antagonist combined with letrozole and mifepristone in preventing early onset of moderate-severe OHSS post oocyte retrieval：a randomized controlled study[J]. J Reprod Med，2019，28（7）：730-735.

叶景欣，钱卫平. 黄体期促性腺激素释放激素拮抗剂在防治卵巢过度刺激综合征的应用进展[J]. 中华生殖与避孕杂志，2017，37（6）：503-506.

YE J X，QIAN W P. Progress of luteal phase gonadotropin-releasing hormone antagonist application in prevention and treatment of ovarian hyperstimulation syndrome[J]. Chin J Reprod Contracept，2017，37（6）：503-506.

PETRENKO A P，CASTELO BRANCO C，MARSHALOV D V，et al. Alternative strategies for the management of ovarian hyperstimulation syndrome，the role of intra-abdominal hypertension control[J]. Gynecol Endocrinol，2020，36（3）：197-203.

LAINAS T G，SFONTOURIS I A，ZORZOVILIS I Z，et al. Management of severe early ovarian hyperstimulation syndrome by re-initiation of GnRH antagonist[J]. Reprod Biomed Online，2007，15（4）：408-412.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical observation of letrozole combined with methylprednisolone in the treatment of infertile patients with polycystic ovary syndrome resistant to clomiphene

Related Author

LIU Shan

GUO Jing

CUI Yalin

CHENG Yayu

DUAN Wei

Related Institution

Dept. of Clinical Laboratory， Qingdao Central Hospital

Dept. of Gynecology， Qingdao Central Hospital

Dept. of Gynecology， Binzhou Medical University Hospital

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰